Kenneth Reed
Vermogen: 4 M $ op 31-05-2026
Vermogen: 4 M $ op 31-05-2026
Kenneth Reed is the founder of Prescient Pharma LLC.
Current jobs include Director at Minerva Biotechnologies Corp.
and Independent Director at RedHill Biopharma Ltd. Education history includes an undergraduate degree from Brown University, a doctorate from the University of Medicine & Dentistry of New Jersey, and an undergraduate degree from Harvard Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-04-2026 | 42.130.000 ( 0,08% ) | 4 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Directeur/Bestuurslid | 15-12-2009 |
Minerva Biotechnologies Corp.
Minerva Biotechnologies Corp. Medical DistributorsDistribution Services Provides medical services | Directeur/Bestuurslid | 21-02-2011 |
| Bedrijven | Functie | Einde |
|---|---|---|
Prescient Pharma LLC | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Minerva Biotechnologies Corp.
Minerva Biotechnologies Corp. Medical DistributorsDistribution Services Provides medical services | Distribution Services |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Prescient Pharma LLC |
Kies jouw editie
Alle financiële informatie op nationaal niveau